Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors
Immunotherapy has become a global focus in cancer treatment and research, with promising results from targeting immune checkpoints in tumors like non-small cell lung cancer, colon cancer, and melanoma. However, resistance to immune checkpoint inhibitors (ICIs) remains a significant challenge. Tradit...
Saved in:
| Main Authors: | Mingxin Guo, Wentong Fang, Zhiqiang Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1429483/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tailoring traditional Chinese medicine in cancer therapy
by: Shuiquan Li, et al.
Published: (2025-01-01) -
Is hyponatremia caused by Chinese herbal medicine a myth? A scoping review and a review of local data in Hong Kong
by: Wu Ping, et al.
Published: (2024-12-01) -
Prediction of traditional Chinese medicine for diabetes based on the multi-source ensemble method
by: Bin Yang, et al.
Published: (2025-01-01) -
Research progress of immune checkpoint inhibitors in the treatment of glioblastoma
by: JIA Xiaorong, et al.
Published: (2024-05-01) -
Research progress of immune checkpoint inhibitors in ovarian cancer
by: Lingli Zhao, et al.
Published: (2024-12-01)